about
Prognostic Genetic Signatures in Upper Tract Urothelial CarcinomaRationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder CancerCurrent status of robotic partial nephrectomy (RPN)Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceTim-2 regulates T helper type 2 responses and autoimmunityRisk factors for the development of parastomal hernia after radical cystectomy.Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.Genomic Characterization of Upper Tract Urothelial CarcinomaRisk of cancer-specific mortality following recurrence after radical nephroureterectomy.Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.Recent advances in robot-assisted radical cystectomy.Impact of gender on bladder cancer incidence, staging, and prognosis.Prognostic factors for upper urinary tract urothelial carcinoma.Immunohistochemical biomarkers for bladder cancer prognosis.Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).Biomolecular predictors of urothelial cancer behavior and treatment outcomes.Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer.Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy.Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy.Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.Cost-effective treatment of low-risk carcinoma not invading bladder muscle.Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder.International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
P50
Q26772220-693C547C-CE27-4417-90FD-30BFA7782F6EQ26772222-470F9B06-544B-4F3B-BD07-7B00BB77EA65Q27005948-69EABD0F-0A21-46AA-9A9C-C50549A40170Q28084159-B43C9726-0A87-43B1-A3DB-EE15AC315C42Q28511160-8B32747A-043E-4BDC-820D-84662C507912Q33220331-B280A25D-DF49-4CAD-AAAE-1D20C879E774Q34143388-F0AD22E8-CB76-49DC-8EAF-C5041D939AF4Q35034441-C1BB850C-EAE4-4B82-9C49-B2A1C36ACA5EQ36362571-42CF0895-EE2D-4C79-A73B-E11C99FDC4BBQ36623107-72D62359-2F52-438D-BF4E-D4806E1E9015Q36773321-978E66BB-9BED-4B80-842A-5887B920C8BDQ37672873-B00398A8-CF4A-44FF-83E0-2F37C52F602CQ37822392-055B727A-2DE9-48F4-883C-80586E6DA480Q37886832-305C6B7E-6061-4323-B2C7-74D770186418Q37897483-6DC6882C-6D42-4C6A-B8C9-B1A5EE7050E0Q37902697-A5AD09F7-E613-4DB9-BF9B-EBF6D3D44DA8Q37950459-736DC461-3A38-49E6-96EF-A953B3E19DD4Q37987066-3133F326-D2E1-4B03-87FE-E02A6511EAE8Q38002448-E519092E-43D1-49BB-BB1F-3483AFFE8555Q38154012-3542DB00-B94D-49EA-BD41-68B9E47D0E51Q38321861-6F41B217-C54E-4B36-9A21-A24A86AC13CAQ38407148-D4DA9017-A9A0-4784-AB9E-4F57F89418ECQ38792051-CE13B5BB-570C-4F54-A1B2-50A64ACDC9F4Q43917433-C18CC1B9-B12F-4A3D-8BB7-1C70DD89484FQ44037317-09340F54-9E6B-4D9F-967E-540FF2B3CA20Q44505483-075352ED-CFF7-4ECC-9156-AFD09E08B3F4Q44519064-935EB6A8-AA03-4453-B048-F66FA2E306E2Q44648038-8DDA3DE2-F48B-4C69-BD0E-6B6EF9482A33Q45049759-4D451671-9B15-4D86-9C16-7748A85376C2Q45202138-8428A74D-C97A-4A07-9381-E952994C1F48Q45657847-EA71BCBD-4426-4A58-ACFC-65CF7E7799ADQ45733362-1E499A24-F39E-4A28-BCE1-FCDB37A6B44FQ45843908-9C5C9444-0570-4FA4-86D3-A91B804976C4Q46489162-4F812B25-00AF-4913-AC3B-7512E2558491Q50491049-54307FC1-0ADF-4D14-AD99-BC70B8E1E388Q50493416-E8F65B8D-0A53-45E7-8548-571C08E87AF7Q50502175-1E2CE80B-AC05-420C-A228-3D858F8C3DC6Q52597038-9DDC7392-FDBE-4C32-B070-1D28D18A1660Q53092088-38B2079A-5C15-4BB5-A115-CFA757980E4AQ53135154-98FA6877-9420-431E-8DCD-873A9AC03871
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eugene K Cha
@nl
Eugene K Cha
@sl
Eugene K. Cha
@en
Eugene K. Cha
@es
type
label
Eugene K Cha
@nl
Eugene K Cha
@sl
Eugene K. Cha
@en
Eugene K. Cha
@es
altLabel
Eugene Cha
@en
prefLabel
Eugene K Cha
@nl
Eugene K Cha
@sl
Eugene K. Cha
@en
Eugene K. Cha
@es
P106
P1153
56091505700
P21
P31
P496
0000-0002-8807-2353